Profiling hemodialysis patients with high ferritin levels

Clinical Nephrology

Volumn 56, Issue 2, 2001, Pages 117-123

  Kirschbaum, B ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Anemia; C reactive protein; Cluster analysis; Ferritin; Hemodialysis; Zinc protoporphyrin

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; ERYTHROPOIETIN; FERRITIN; HEMOGLOBIN; IRON; PROTOPORPHYRIN ZINC; ZINC;

ANEMIA; ARTICLE; CLINICAL STUDY; CLUSTER ANALYSIS; CONTROLLED STUDY; DATA ANALYSIS; ERYTHROPOIESIS; HEMODIALYSIS PATIENT; HUMAN; HUMAN TISSUE; HYPERFERRITINEMIA; INFLAMMATION; IRON KINETICS; IRON OVERLOAD; LABORATORY TEST; MAJOR CLINICAL STUDY;

ALBUMINS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CLUSTER ANALYSIS; FERRITINS; HEMOGLOBINS; HUMANS; IRON OVERLOAD; PROTOPORPHYRINS; RENAL DIALYSIS;

EID: 0034906122     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Transferrin receptor assay and zinc protoporphyrin as markers of iron-deficient erythropoiesis in end-stage renal disease patients
2. Erythrocyte zinc protoporphyrin
3. Effect of iron overload and iron deficiency on atherosclerosis in the hypercholesterolemic rabbit
4. Iron, atherosclerosis, and ischemic heart disease
5. Bioavailability of iron in hemodialysis patients treated with erythropoietin: Evidence for the inhibitory role of aluminum
6. Management of iron deficiency in renal anemia: Guidelines for the optimal therapeutic approach in erythropoietin-treated patients
7. Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries
8. Hematologic problems of dialysis patients
9. The evaluation of iron status in hemodialysis patients
10. The utility of zinc protoporphyrin for predicting the need for intravenous iron therapy in hemodialysis patients
11. Acute-phase proteins and other systemic responses to inflammation
12. Zinc protoporphyrin and iron-deficient erythropoiesis
13. Antioxidant protection against organic and inorganic oxygen radicals by normal human plasma: The important primary role for iron-binding and iron-oxidizing proteins
14. Relationship of serum ferritin concentrations with metabolic cardiovascular risk factors in men without evidence for coronary artery disease
15. Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients
16. Hypotransferrinemia of chronically hemodialyzed patients
17. Observations on the zinc protoporphyrin/heme ratio in whole blood
18. A clinical evaluation of serum ferritin as an index of iron stores
19. Low iron binding capacity as a risk factor for myocardial infarction
20. Regulation of complement activation by C-reactive protein
21. Transferrin biochemistry, physiology, and clinical significance
22. DOQI clinical practice guidelines for the treatment of the anemia of chronic renal failure
23. Outcome prediction by traditional and new markers of inflammation in patients with sepsis
24. C-reactive protein as an outcome predictor for maintenance hemodialysis patients
25. Plasma C-reactive protein in hemodialysis
26. Body iron stores, dietary iron intake, and coronary heart disease
27. Detection of acute-phase response and infection. The role of procalcitonin and C-reactive protein
28. High stored iron levels are associated with excess risk of myocardial infarction in Eastern Finnish men
29. C-reactive protein: Structural biology and host defense function
30. Intravenous ascorbic acid as an adjunct therapy for recombinant erythropoietin in hemodialysis patients with hyperferritinemia